Health Canada drug identification number

DIN 02567334 — VUEWAY 485.1 MG

VUEWAY is a solution of Gadopiclenol marketed by BRACCO IMAGING CANADA. The full Gadopiclenol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02567334
Brand name
VUEWAY
Active ingredient
Gadopiclenol
Strength
485.1 MG
Dosage form
SOLUTION
Route
INTRAVENOUS
Manufacturer
BRACCO IMAGING CANADA
Health Canada status
MARKETED
Drug class
Gadolinium-based contrast agent (macrocyclic nonionic GBCA)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.